ARCHIVES

Clinical Trials: For ER+ Breast Cancer, Post-Tamoxifen, NSABP Testing Aromasin In Large Trial

This article is from The Cancer Letter archive.

Vol. 27 No. 22 | June 1, 2001

Download PDF Visit The Full Archive

Related Articles

FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer

January 28, 2005

High Dose Radiotherapy Plus Chemo Encouraging For Small Cell Lung Cancer

November 27, 2009

Study Tests PARP Inhibitor ABT-888 For Several Cancers

September 25, 2009

“I’m Not Bummed Out By This” – Broder

December 22, 1994

In Brief: Hawkins Gets Seat Back On Labor & Human Resources, Loses Subcommittee; Foundation Offers Fellowships

February 11, 1983

Blood Cancers Advocacy Groups Seek DOD And NCI Funds, Medicare Coverage.

July 6, 2001